Perceived adverse effects of nanoscience and nanotechnologies (NTs) on health, safety, and environment (EHS) can impede the progress, competitiveness, and responsible and sustainable development of NT across a wide range of industrial sectors. Studies on the interaction of man-made nanostructured materials and living organism are still in their infancy.
Opportunities and innovative products of NTs in the health sector are coming, along with challenges in the regulation of these products, posing great challenges to existing legislative frameworks. The predominant areas of use of NT in medicine, classified as nanomedicine, are in drug delivery and as diagnostic imaging and biosensors.
Current fragmented regulatory regimes across the world, though considered adequate, have potential gaps that prevent comprehensive regulation of NT. There is a general consensus for an internationally integrated NT governance to address the ethical, legal, and social aspects of the NT.
Legal metrology's (LM's) scope concerning the EHS and trade measurements seems to be the ideal platform to address the impact of NT. This work explores the feasibility of LM as a platform to address the impact of NT on EHS, legal, and socioeconomic aspects. LM's objectives relate to harmonized regulation and measurements, not exclusively to measurement range or technology, such as macro, micro, meso, nano, or space and biotechnologies.
|Title of host publication||Characterization and biology of nanomaterials for drug delivery|
|Subtitle of host publication||nanoscience and nanotechnology in drug delivery|
|Editors||Shyam S. Mohapatra, Shivendu Ranjan, Nandita Dasgupta, Raghvendra Kumar Mishra, Sabu Thomas|
|Place of Publication||Amsterdam; Oxford, UK; Cambridge, US|
|Number of pages||46|
|Publication status||Published - 2019|
|Name||Micro and Nano Technologies Series|
- Harmonized global regulatory framework
- Legal metrology
- Safety and environment